Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1974-08-22
1977-09-27
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544163, 544 58, 260268PH, 260268CN, 26029385, 26029386, 26029387, 2602948E, 26032643, 260465D, 42424855, 424267, 424274, 424300, 424304, 42424854, C07D29500
Patent
active
040512428
ABSTRACT:
Therapeutically-active and pharmacologically-acceptable N-acyl-N" -(3-amino-2-cyanoacryloyl)-formamidrazones and their pharmaceutically-acceptable acid-addition salts inhibit xanthine oxidase and are useful as the active ingredient in medicaments for the treatment of gout.
REFERENCES:
patent: 3923817 (1975-12-01), Klemm
Klemm Kurt
Langenscheid Erhard
ByK Gulden Lomberg Chemische Fabrik GmbH
Killos Paul J.
LandOfFree
Substituted N-acyl-N"-(3-amino-2-cyanoacryloyl-)formamidrazones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted N-acyl-N"-(3-amino-2-cyanoacryloyl-)formamidrazones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted N-acyl-N"-(3-amino-2-cyanoacryloyl-)formamidrazones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1815154